<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2(Suppl 3)</volume><submitter>Meyerhardt J</submitter><journal>Journal for immunotherapy of cancer</journal><pagination>P71-P71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4288729</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer</pubmed_title><pmcid>PMC4288729</pmcid><pubmed_authors>Gargano M</pubmed_authors><pubmed_authors>Grady M</pubmed_authors><pubmed_authors>Braun A</pubmed_authors><pubmed_authors>Huhn R</pubmed_authors><pubmed_authors>Meyerhardt J</pubmed_authors><pubmed_authors>Lowe J</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer</name><description/><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jan</publication><modification>2025-04-22T07:11:20.544Z</modification><creation>2025-04-05T22:03:27.554Z</creation></dates><accession>S-EPMC4288729</accession><cross_references/></HashMap>